Method for delivery of pharmaceuticals for treating or preventing presbyopia
Embodiments of the present invention relate to a method for delivering pharmaceuticals to the lens of the eye to treat or prevent presbyopia. According to the embodiments, pharmaceuticals may be applied by providing the pharmaceuticals to the eye and promoting delivery of the pharmaceuticals into the lens capsule and/or lens fibers of the lens of the eye. Methods include iontophoresis, nano-medication, and photonic activation to deliver the pharmaceuticals to treat or prevent presbyopia.
1. A method for delivering a pharmaceutical substance comprising:
providing a pharmaceutical substance to an eye; and
promoting delivery of the pharmaceutical substance into the lens capsule and/or lens fibers of the eye, wherein promoting delivery comprises using iontophoresis to urge the substance, in a charged state, into the lens capsule and/or the lens fibers.
2. The method of claim 1 , wherein using iontophoresis comprises:
applying the substance, in the charged state, to the eye;
applying an electric voltage to an area around the eye;
forming an electric field from the electric voltage through the lens of the eye, the electric field being large enough to urge the substance, in the charged state, to the lens capsule and/or the lens fibers; and
discontinuing the electric voltage.
3. A method for nano-medication comprising:
providing a nanometer-scaled pharmaceutical substance to an eye; and
promoting delivery of the nanometer-scaled pharmaceutical substance into the lens capsule and/or lens fibers of the eye.
4. The method of claim 3 , wherein the nanometer-scaled pharmaceutical substance comprises encapsulated nano-micelles.
5. A method for delivering a pharmaceutical substance comprising:
providing a pharmaceutical substance to an eye; and
promoting delivery of the pharmaceutical substance into the lens capsule and/or lens fibers of the eye, wherein promoting delivery comprises using photonic activation to activate an inert form of the substance in the lens capsule and/or the lens fibers.
6. The method of claim 5 , wherein using photonic activation comprises:
applying the inert form of the substance to the eye, wherein the substance diffuses to the lens capsule and/or the lens fibers; and
applying photons to the inert form of the substance to activate the inert form of the substance.
7. The method of claim 6 , wherein applying photons comprises: applying different levels of photon energy to different areas of the lens capsule and/or the lens fibers to activate the inert form of the substance to different activity levels.
8. The method of claim 5 , wherein using photonic activation includes supplying photons from a laser or an LED.
9. The method of claim 1 , further comprising breaking chemical bonds that crosslink lens fibers together thus increasing distensibility in the lens capsule and/or the lens fibers of the eye.
10. The method of claim 1 , wherein the pharmaceutical substance is delivered to the lens capsule.
11. The method of claim 1 , wherein the pharmaceutical substance is delivered to the lens fibers.
12. The method of claim 3 , further comprising breaking chemical bonds that crosslink lens fibers together thus increasing distensibility in the lens capsule and/or the lens fibers of the eye.
13. The method of claim 3 , wherein the pharmaceutical substance is delivered to the lens capsule.
14. The method of claim 3 , wherein the pharmaceutical substance is delivered to the lens fibers.
15. The method of claim 5 , further comprising breaking chemical bonds that crosslink lens fibers together thus increasing distensibility in the lens capsule and/or the lens fibers of the eye.
16. The method of claim 5 , wherein the pharmaceutical substance is delivered to the lens capsule.
17. The method of claim 5 , wherein the pharmaceutical substance is delivered to the lens fibers.